Xact Kapitalforvaltning’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $4.2M | Sell |
46,750
-2,574
| -5% | -$231K | 0.09% | 195 |
|
|
2019
Q4 | $5.33M | Buy |
49,324
+1,611
| +3% | +$174K | 0.09% | 205 |
|
|
2019
Q3 | $4.67M | Buy |
47,713
+4,288
| +10% | +$420K | 0.09% | 210 |
|
|
2019
Q2 | $5.69M | Buy |
43,425
+2,185
| +5% | +$286K | 0.12% | 169 |
|
|
2019
Q1 | $5.58M | Buy |
41,240
+4,507
| +12% | +$609K | 0.13% | 160 |
|
|
2018
Q4 | $3.58M | Sell |
36,733
-8,532
| -19% | -$831K | 0.09% | 206 |
|
|
2018
Q3 | $6.29M | Sell |
45,265
-1,605
| -3% | -$223K | 0.13% | 150 |
|
|
2018
Q2 | $5.82M | Sell |
46,870
-1,882
| -4% | -$234K | 0.12% | 163 |
|
|
2018
Q1 | $5.43M | Buy |
48,752
+2,920
| +6% | +$325K | 0.12% | 171 |
|
|
2017
Q4 | $5.48M | Buy |
45,832
+3,789
| +9% | +$453K | 0.13% | 171 |
|
|
2017
Q3 | $5.9M | Buy |
42,043
+537
| +1% | +$75.3K | 0.17% | 136 |
|
|
2017
Q2 | $5.05M | Buy |
41,506
+5,076
| +14% | +$618K | 0.15% | 154 |
|
|
2017
Q1 | $4.42M | Buy |
36,430
+2,434
| +7% | +$295K | 0.14% | 175 |
|
|
2016
Q4 | $4.16M | Buy |
33,996
+1,817
| +6% | +$222K | 0.15% | 161 |
|
|
2016
Q3 | $3.94M | Buy |
+32,179
| New | +$3.94M | 0.14% | 163 |
|